POL Guide - 2020 - 61

pt/inr

CoaguChek XS® System
PT/INR Monitoring Solution
The next generation in point-of-care prothrombotin (PT) and international
normalized ratio (INR) testing, this new system uses exclusive smart
technology to help ensure accurate results and offers the flexibility and control
that health care professionals need to confidently manage a wide range
of anticoagulated patients. It is the only system to perform onboard quality
control and determine patient results in a single test chamber.
* CLIA waived
* Neutralizes therapeutic levels of heparin and LMWH
* INR corrected for hematocrit within specified range;
manage a broad array of patients with a single device
* Small sample size (10 µL) for easy dosing
* Strip allows dosing from either top or side for simple
blood application
* Small, battery-powered, handheld meter for portability
and efficiency
* New onboard controls; no external QC necessary
* Auto-on with strip insertion and auto-off capabilities
* 18-month strip shelf life; no refrigeration needed
* Made in the USA

XS® System
(891-0581)���������������������������������������������������������� ea
Strips for XS & XS Plus Meters
(891-7593)��������������������������������������������������� 48/box
Contains: 24 strips per bottle, 2 bottles per box.

Controls, Hi & Lo
(109-9989)���������������������������������������������������������� ea

Realize the value of
Point-of-Care PT/INR testing
with CoaguChek® solutions
Point-of-care (POC) PT/INR testing can be a valuable component of a
successful warfarin therapy program. Rather than sending patient blood
samples to the lab and waiting days for results, in-office testing:
* Enables immediate therapy decisions by delivering
on-the-spot results
* Saves valuable time and unnecessary steps
* Helps reduce risk and cost of treatment related
complications1
* Improves patient satisfaction2

To learn more about POC PT/INR testing with
CoaguChek systems, visit coaguchek-usa.com

1 Wurster M, et al. Dis Manag. 2006 2 Campbell PM, et al.
Dis Manag Clin Outcomes. 2002
2 Giles T, Roffidal L. Results of the prothrombin
office-testing benefit evaluation [PROBE]. Cardiovasc
Rev Rep. 2002;23:27-33.

henryschein.com/medical

19MS4288

19MS4288_POL_50-65.indd 61

2/3/20 8:16 AM

http://www.henryschein.com/redirect.aspx?did=medical&returnurl=/us-en/Shopping/ProductDetails.aspx%3Fproductid%3D8910581%26CatalogName%3DMEDICAL%26utm_source%3DMedical%26utm_medium%3DNxtbook%26utm_campaign%3Dpol-2020%26utm_term%3D8910581 http://www.henryschein.com/redirect.aspx?did=medical&returnurl=/us-en/Shopping/ProductDetails.aspx%3Fproductid%3D8917593%26CatalogName%3DMEDICAL%26utm_source%3DMedical%26utm_medium%3DNxtbook%26utm_campaign%3Dpol-2020%26utm_term%3D8917593 http://www.henryschein.com/redirect.aspx?did=medical&returnurl=/us-en/Shopping/ProductDetails.aspx%3Fproductid%3D1099989%26CatalogName%3DMEDICAL%26utm_source%3DMedical%26utm_medium%3DNxtbook%26utm_campaign%3Dpol-2020%26utm_term%3D1099989 http://www.coaguchek-usa.com http://www.henryschein.com/medical

POL Guide - 2020

Table of Contents for the Digital Edition of POL Guide - 2020